DK0497158T3 - Farmaceutisk tyggegummi med acetylsalicylsyre - Google Patents

Farmaceutisk tyggegummi med acetylsalicylsyre

Info

Publication number
DK0497158T3
DK0497158T3 DK92100701.9T DK92100701T DK0497158T3 DK 0497158 T3 DK0497158 T3 DK 0497158T3 DK 92100701 T DK92100701 T DK 92100701T DK 0497158 T3 DK0497158 T3 DK 0497158T3
Authority
DK
Denmark
Prior art keywords
chewing gum
acetylsalicylic acid
pharmaceutical chewing
pharmaceutical
stable
Prior art date
Application number
DK92100701.9T
Other languages
English (en)
Inventor
Thomas Dr Valeri
Franz Dr Haeusler
Joachim Dr Maasz
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0497158T3 publication Critical patent/DK0497158T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92100701.9T 1991-01-30 1992-01-17 Farmaceutisk tyggegummi med acetylsalicylsyre DK0497158T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4102629A DE4102629A1 (de) 1991-01-30 1991-01-30 Pharmazeutischer kaugummi mit acetylsalicylsaeure

Publications (1)

Publication Number Publication Date
DK0497158T3 true DK0497158T3 (da) 1996-07-22

Family

ID=6423945

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92100701.9T DK0497158T3 (da) 1991-01-30 1992-01-17 Farmaceutisk tyggegummi med acetylsalicylsyre

Country Status (9)

Country Link
US (1) US5922347A (da)
EP (1) EP0497158B1 (da)
JP (1) JPH04312532A (da)
AT (1) ATE135221T1 (da)
CA (1) CA2060068A1 (da)
DE (2) DE4102629A1 (da)
DK (1) DK0497158T3 (da)
ES (1) ES2086011T3 (da)
GR (1) GR3019324T3 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2308299A (en) * 1995-12-19 1997-06-25 Paul Dudley White Indigestion remedy containing an antacid and aspirin
DE19615820A1 (de) * 1996-04-06 1997-10-09 Holger Specht Zahnpflegemittel und Verfahren zu seiner Herstellung
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
DE19913731A1 (de) * 1999-03-26 2000-09-28 Lohmann Therapie Syst Lts Medizinische Zubereitung, enthaltend als Wirkstoff zumindest einen Anteil von Acetylsalicylsäure
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US7935362B2 (en) 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US6582738B2 (en) 1999-09-13 2003-06-24 Deseret Laboratories, Inc. Process for preparing chewing gum containing a nutritional supplement
US6322828B1 (en) 1999-09-13 2001-11-27 Deseret Laboratories, Inc. Process for manufacturing a pharmaceutical chewing gum
AU3885201A (en) 1999-09-20 2001-04-24 Mastercare Diet and weight control gum and sucker
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
FR2833173B1 (fr) * 2001-12-10 2004-08-27 Roquette Freres Preparation antipyretique renfermant du xylitol
US8602774B2 (en) 2002-12-04 2013-12-10 Bryan Wasylucha Process of tooth whitening and apparatus therefor
DE10349050A1 (de) * 2003-10-17 2005-05-12 Nova Dentalia Zahnpflege Gmbh Kaumasse zur Remineralisation von Zahnschmelz
WO2006012213A2 (en) * 2004-06-25 2006-02-02 Tea Guard Llc Composition and method for delivery of phytochemicals
US20060078508A1 (en) * 2004-10-13 2006-04-13 Cadbury Adams Usa Llc Effervescent pressed gum tablet compositions
WO2007047951A2 (en) * 2005-10-20 2007-04-26 University Of South Florida Molecular delivery to cells using aspirin-related compounds
CN101791033A (zh) * 2010-04-08 2010-08-04 杨柏 一种口香含片的制造方法
EP3513787A1 (en) 2011-01-10 2019-07-24 Invion, Inc Use of beta-adrenergic inverse agonists for smoking cessation
WO2016130830A1 (en) 2015-02-11 2016-08-18 The Fix, Llc Compositions and methods for combination ingredient delivery

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1630763A (en) * 1925-06-26 1927-05-31 Paul H Raymer Chewing gum
US2262087A (en) * 1940-05-21 1941-11-11 White Lab Inc Chewing gum tablet
US2465233A (en) * 1946-05-03 1949-03-22 Wolf Motion sickness chewing gum
US2922747A (en) * 1957-06-14 1960-01-26 American Chicle Co Deodorant composition
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
CA1165242A (en) * 1981-07-01 1984-04-10 Hovsep Simonian Compressed and formed alkaline component suitable for use in buffered acetylsalicylic acid product
CA1240875A (en) * 1984-01-31 1988-08-23 Subraman R. Cherukuri Tableted chewing gum composition and method of preparation
US4753805A (en) * 1984-01-31 1988-06-28 Warner-Lambert Company Tabletted chewing gum composition and method of preparation
US4937076A (en) * 1984-08-10 1990-06-26 Combe Incorporated Chewable aspirin and buffering material tablet and method for producing same
US4894234A (en) * 1984-10-05 1990-01-16 Sharma Shri C Novel drug delivery system for antiarrhythmics
US4879108A (en) * 1985-12-20 1989-11-07 Warner-Lambert Company Confectionery delivery system for antipyretics
ZA87994B (en) * 1986-02-27 1987-09-30 Warner Lambert Co Antacid chewing gum
US4820523A (en) * 1986-04-15 1989-04-11 Warner-Lambert Company Pharmaceutical composition
US4741905A (en) * 1986-06-19 1988-05-03 Warner-Lambert Company Chewing gum candy
US4828820A (en) * 1987-01-15 1989-05-09 Warner-Lambert Company Chewable tooth cleaning composition
FR2611501B1 (fr) * 1987-03-04 1991-12-06 Corbiere Jerome Nouvelles compositions pharmaceutiques pour la voie buccale a base d'acetylsalielylate de lysine et leur procede d'obtention
US4975270A (en) * 1987-04-21 1990-12-04 Nabisco Brands, Inc. Elastomer encased active ingredients

Also Published As

Publication number Publication date
ATE135221T1 (de) 1996-03-15
EP0497158B1 (de) 1996-03-13
EP0497158A1 (de) 1992-08-05
ES2086011T3 (es) 1996-06-16
DE59205630D1 (de) 1996-04-18
US5922347A (en) 1999-07-13
CA2060068A1 (en) 1992-07-31
JPH04312532A (ja) 1992-11-04
GR3019324T3 (en) 1996-06-30
DE4102629A1 (de) 1992-08-06

Similar Documents

Publication Publication Date Title
DK0497158T3 (da) Farmaceutisk tyggegummi med acetylsalicylsyre
CA2158630A1 (en) Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
NO941678D0 (no) nor-gallesyrederivater, fremgangsmåte for fremstilling og anvendelse av dem som legemiddel
PT96506A (pt) Processo para a preparacao de composicoes orais que incorporam como ingrediente activo pimobendano
DK515489D0 (da) Dispergerbar laegemiddelformulering
ES2179832T3 (es) Formas de administracion orales con contenido en flupirtina solida, con liberacion controlada del principio activo.
JPS5753414A (en) Stabilized medicinal composition
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
IT1284604B1 (it) Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
FI945510A0 (fi) Klavulaanihapon diamiinisuolat
ES2054089T3 (es) Formulaciones orales liquidas.
FR2691149B1 (fr) Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
GR3004863T3 (da)
DE59501945D1 (de) Orale Arzeimittelzubereitung enthaltend Diclofenac-Natrium und eine organische Säure
FR2602144B1 (fr) Medicament a base de produits vegetaux, actif contre les nausees, les vomissements et les troubles analogues
FR2694005B1 (fr) Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
NO870950L (no) FremgangsmŸte for fremstilling av et stabilt injiserbart farmasŸytisk preparat.
DE3887201D1 (de) Erythromycin-Derivate und ihre Herstellung und Verwendung.
FR2691967B1 (fr) Nouveaux composes pyrrolothienopyraziniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ITMI913511A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ATE181828T1 (de) Oral anzuwendendes arzneimittel bestehend aus ibuprofen
ITRM910038A0 (it) Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale.
ITMI911842A1 (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITMI911841A1 (it) Derivati dell'eseridina utili per il trattamento delle malattie associaate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.